228 related articles for article (PubMed ID: 35051676)
1. The detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alpha.
Taxier LR; Philippi SM; York JM; LaDu MJ; Frick KM
Neurobiol Aging; 2022 Apr; 112():74-86. PubMed ID: 35051676
[TBL] [Abstract][Full Text] [Related]
2. APOE4 homozygote females are resistant to the beneficial effects of 17β-estradiol on memory and CA1 dendritic spine density in the EFAD mouse model of Alzheimer's disease.
Taxier LR; Philippi SM; Fleischer AW; York JM; LaDu MJ; Frick KM
Neurobiol Aging; 2022 Oct; 118():13-24. PubMed ID: 35843109
[TBL] [Abstract][Full Text] [Related]
3. Independent APOE4 knock-in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines.
Sepulveda J; Luo N; Nelson M; Ng CAS; Rebeck GW
J Neurochem; 2022 Nov; 163(3):247-259. PubMed ID: 35838553
[TBL] [Abstract][Full Text] [Related]
4. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3.
Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L
Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668
[TBL] [Abstract][Full Text] [Related]
5. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.
Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM
Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252
[TBL] [Abstract][Full Text] [Related]
6. APOE4 genotype or ovarian hormone loss influence open field exploration in an EFAD mouse model of Alzheimer's disease.
Taxier LR; Philippi SM; York JM; LaDu MJ; Frick KM
Horm Behav; 2022 Apr; 140():105124. PubMed ID: 35101701
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
[TBL] [Abstract][Full Text] [Related]
8. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
[TBL] [Abstract][Full Text] [Related]
9. Higher Neuronal Facilitation and Potentiation with APOE4 Suppressed by Angiotensin II.
Scheinman SB; Tseng KY; Alford S; Tai LM
Mol Neurobiol; 2024 Jan; 61(1):120-131. PubMed ID: 37589833
[TBL] [Abstract][Full Text] [Related]
10. The influence of chronic stress on anxiety-like behavior and cognitive function in different human GFAP-ApoE transgenic adult male mice.
Meng FT; Zhao J; Fang H; Liu YJ
Stress; 2015; 18(4):419-26. PubMed ID: 25938810
[TBL] [Abstract][Full Text] [Related]
11. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
12. Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development.
Jain S; Yoon SY; Leung L; Knoferle J; Huang Y
PLoS One; 2013; 8(3):e59478. PubMed ID: 23527202
[TBL] [Abstract][Full Text] [Related]
13. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo.
Dumanis SB; Tesoriero JA; Babus LW; Nguyen MT; Trotter JH; Ladu MJ; Weeber EJ; Turner RS; Xu B; Rebeck GW; Hoe HS
J Neurosci; 2009 Dec; 29(48):15317-22. PubMed ID: 19955384
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene.
Sun GZ; He YC; Ma XK; Li ST; Chen DJ; Gao M; Qiu SF; Yin JX; Shi J; Wu J
CNS Neurosci Ther; 2017 Sep; 23(9):748-758. PubMed ID: 28786172
[TBL] [Abstract][Full Text] [Related]
15. ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro.
Nwabuisi-Heath E; Rebeck GW; Ladu MJ; Yu C
ASN Neuro; 2014 Jan; 6(1):e00134. PubMed ID: 24328732
[TBL] [Abstract][Full Text] [Related]
16. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
[TBL] [Abstract][Full Text] [Related]
17. Contributions of sex and genotype to exploratory behavior differences in an aged humanized
McLean JW; Bhattrai A; Vitali F; Raikes AC; Wiegand JL; Brinton RD
Learn Mem; 2022 Sep; 29(9):321-331. PubMed ID: 36206387
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation.
Valencia-Olvera AC; Balu D; Faulk N; Amiridis A; Wang Y; Pham C; Avila-Munoz E; York JM; Thatcher GRJ; LaDu MJ
Neurotherapeutics; 2023 Jul; 20(4):1120-1137. PubMed ID: 37157042
[TBL] [Abstract][Full Text] [Related]
19. Estradiol improves behavior in FAD transgenic mice that express
Balu D; Valencia-Olvera AC; Deshpande A; Narayanam S; Konasani S; Pattisapu S; York JM; Thatcher GRJ; LaDu MJ; Tai LM
Front Endocrinol (Lausanne); 2024; 15():1374825. PubMed ID: 38742194
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain.
Teter B; LaDu MJ; Sullivan PM; Frautschy SA; Cole GM
Neuroreport; 2016 Aug; 27(11):791-5. PubMed ID: 27281274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
